ProKidney
PROK
56 hedge funds and large institutions have $20.9M invested in ProKidney in 2025 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 33 closing their positions.
9.87% less ownership
Funds ownership: 37.05% → 27.19% (-9.9%)
13% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 16
19% less funds holding
Funds holding: 69 → 56 (-13)
39% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 33
50% less capital invested
Capital invested by funds: $42M → $20.9M (-$21.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$1.26M |
| 2 |
Jane Street
New York
|
+$461K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$398K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$362K |
| 5 |
Goldman Sachs
New York
|
+$283K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.89M |
| 2 |
Morgan Stanley
New York
|
-$3.39M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.84M |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.07M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.02M |
PROK Hedge Fund Activity: Q2 2025 in Review
56 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q2 2025, worth a combined $20.9M — down 50% from $42M a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of PROK and 20 opened new positions — a net loss of 13 holders — while 16 trimmed existing stakes and 14 added.
The largest buyer was JP Morgan Chase, adding an estimated $1.26M. The largest seller was BlackRock, cutting an estimated $3.89M.
- 56 institutional investors held ProKidney (PROK) as of Q2 2025, down from 69 in Q1 2025.
- Funds reported $20.9M of ProKidney stock for Q2 2025, down 50% quarter-over-quarter.
- 20 funds opened new ProKidney positions in Q2 2025 and 33 closed out, a net change of -13 holders.
- The largest ProKidney buyer in Q2 2025 was JP Morgan Chase, an estimated $1.26M added.
- The largest ProKidney seller in Q2 2025 was BlackRock, an estimated $3.89M sold.
Based on aggregated 13F filings for Q2 2025.